Articles in this section

  • Hepatitis C among People who use drugs 61th CND Side Event (March 2018)

  • Rwanda: A model for hepatitis C care in resource-limited settings?

  • Tackling hepatitis C – Pakistan’s road to success

  • Civil Society Groups Tell UNITAID: Support access mechanisms led by civil society, not the pharmaceutical industry Letters from global groups express deep concerns about the Medicines Patent Pool’s entry into hepatitis C treatment